An op-ed criticizes the CDC acting director's call to develop separate vaccines for measles, mumps, and rubella, arguing that it lacks scientific basis, would hinder vaccination efforts, and could lead to increased disease outbreaks, emphasizing the proven success and safety of the current combined MMR vaccine.
Pfizer and Moderna are developing new versions of their Covid vaccines that aim to provide broader and longer-lasting immunity against the virus, and combination jabs that protect against Covid and other respiratory diseases in a single dose. Both companies aim to keep up with a shift in the US toward annual Covid shots rather than frequent booster doses. Pfizer and BioNTech are developing a vaccine that targets both Covid and the flu, while Moderna is developing a triple combination shot, which would target Covid, the flu, and RSV all at once.